Skip to content

Drug interactions

Oteseconazole + Sofosbuvir-velpatasvir-voxilaprevir

Severity: Minor

Oteseconazole and Sofosbuvir-velpatasvir-voxilaprevir: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Oteseconazole inhibits BCRP and may increase exposure to sofosbuvir and voxilaprevir, both of which are BCRP substrates. The increase is expected to be modest and is unlikely to be clinically significant in most patients.

What this interaction means in plain words

Oteseconazole and Sofosbuvir-velpatasvir-voxilaprevir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Oteseconazole belongs to Anti Fungals; Sofosbuvir-velpatasvir-voxilaprevir belongs to Anti Virals.

Evidence level: Low

Why it happens

Oteseconazole inhibits intestinal BCRP efflux, which may increase absorption of BCRP substrates such as sofosbuvir and voxilaprevir.

What to do

No empirical dose change is required. Monitor for adverse effects of the antiviral combination and liver function.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Oteseconazole and Sofosbuvir-velpatasvir-voxilaprevir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Oteseconazole with Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp rates the interaction as minor. Oteseconazole and Sofosbuvir-velpatasvir-voxilaprevir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Oteseconazole inhibits BCRP and may increase exposure to sofosbuvir and voxilaprevir, both of which are BCRP substrates. The increase is expected to be modest and is unlikely to be clinically significant in most patients.

How serious is the interaction between Oteseconazole and Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No empirical dose change is required. Monitor for adverse effects of the antiviral combination and liver function.

What other medicines interact with Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp also lists interactions of Sofosbuvir-velpatasvir-voxilaprevir with, for example, Fosphenytoin, Phenobarbital, Phenytoin. The full list is on the Sofosbuvir-velpatasvir-voxilaprevir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in